Recent Finacing
Recent Raise
Azaya Therapeutics develops a Protein Stabilized Nanoparticle platform to create targeted, safer formulations of chemotherapy, advancing ATI-1123, a Taxotere reformulation, toward clinical testing from San Antonio.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor